
Seaport Therapeutics, Inc. Common Stock
SPTXHealthcare|Biotechnology|US
$21.50
+1.11 (+5.44%)
DCF Value
$1.08
Tangible Book / Share
$7.42
Cash / Share
$5.43
Ownership Breakdown
34.4%
Float
53.5M
Shares Outstanding
18.4M
Float Shares
Major Holders (28)
Combined: 364.3%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| PureTech LYT, Inc. | Corporation | 31.20% | 16,685,013 | Aug 14, 2026 | 13D/G |
| PureTech Health LLC | Other | 31.20% | 16,685,013 | Aug 14, 2026 | 13D/G |
| PureTech Health plc | Corporation | 31.20% | 16,685,013 | Aug 14, 2026 | 13D/G |
| Kristina Burow | Individual | 11.90% | 6,294,951 | May 6, 2026 | 13D/G |
| Steven Gillis | Individual | 11.90% | 6,294,951 | May 6, 2026 | 13D/G |
| Keith Crandell | Individual | 11.90% | 6,294,951 | May 6, 2026 | 13D/G |
| Robert Nelsen | Individual | 11.90% | 6,294,951 | May 6, 2026 | 13D/G |
| ARCH Venture Partners XII, LLC | Other | 11.90% | 6,294,951 | May 6, 2026 | 13D/G |
| ARCH Venture Partners XII, L.P. | Partnership | 11.90% | 6,294,951 | May 6, 2026 | 13D/G |
| ARCH Venture Fund XII, L.P. | Partnership | 11.90% | 6,294,951 | May 6, 2026 | 13D/G |
| General Atlantic (SP), L.P. | Partnership | 11.50% | 6,101,582 | May 11, 2026 | 13D/G |
| General Atlantic Partners (Lux) SCSp | Partnership | 11.50% | 6,101,582 | May 11, 2026 | 13D/G |
| General Atlantic GenPar, L.P. | Partnership | 11.50% | 6,101,582 | May 11, 2026 | 13D/G |
| GAP Coinvestments III, LLC | Other | 11.50% | 6,101,582 | May 11, 2026 | 13D/G |
| GAP Coinvestments IV, LLC | Other | 11.50% | 6,101,582 | May 11, 2026 | 13D/G |
| GAP Coinvestments V, LLC | Other | 11.50% | 6,101,582 | May 11, 2026 | 13D/G |
| GAP Coinvestments CDA, L.P. | Partnership | 11.50% | 6,101,582 | May 11, 2026 | 13D/G |
| General Atlantic GenPar (Lux) SCSp | Partnership | 11.50% | 6,101,582 | May 11, 2026 | 13D/G |
| General Atlantic (Lux) S.a r.l. | Holding company | 11.50% | 6,101,582 | May 11, 2026 | 13D/G |
| GAP (Bermuda) L.P. | Partnership | 11.50% | 6,101,582 | May 11, 2026 | 13D/G |
| General Atlantic GenPar (Bermuda), L.P. | Partnership | 11.50% | 6,101,582 | May 11, 2026 | 13D/G |
| General Atlantic, L.P. | Partnership | 11.50% | 6,101,582 | May 11, 2026 | 13D/G |
| General Atlantic (SPV) GP, LLC | Other | 11.50% | 6,101,582 | May 11, 2026 | 13D/G |
| General Atlantic Partners 100, L.P. | Partnership | 11.50% | 6,101,582 | May 11, 2026 | 13D/G |
| Zohar Daphne | Individual | 9.10% | 5,225,497 | Aug 5, 2026 | 13D/G |
| Paul Steven M | Individual | 6.30% | 3,516,718 | Aug 5, 2026 | 13D/G |
| The Goldman Sachs Group, Inc. | HC, CO | 5.50% | 2,791,814 | May 11, 2026 | 13D/G |
| Goldman Sachs & Co. LLC | BD, IA, OO | 5.50% | 2,791,814 | May 11, 2026 | 13D/G |
Insider Trades (12)
Last 4 quarters: 16,400,534 acquired · 51,452,630 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Torres Denice | director | Nov 3, 2026 | BUY | 5,000 | $19.86 | $99.3K | Form 4 |
| HOMBACH ROBERT J. | director | Jun 22, 2026 | BUY | 13,000 | $18.14 | $235.8K | Form 4 |
| PureTech Health plc | 10 percent owner | May 4, 2026 | CONVERSION | 965,255 | — | — | Form 4 |
| PureTech Health plc | 10 percent owner | May 4, 2026 | CONVERSION | 2,681,265 | — | — | Form 4 |
| PureTech Health plc | 10 percent owner | May 4, 2026 | CONVERSION | 12,736,014 | — | — | Form 4 |
| PureTech Health plc | 10 percent owner | May 4, 2026 | CONVERSION | 8,421,052 | — | — | Form 4 |
| PureTech Health plc | 10 percent owner | May 4, 2026 | CONVERSION | 40,000,000 | — | — | Form 4 |
| PureTech Health plc | 10 percent owner | May 4, 2026 | CONVERSION | 3,031,578 | — | — | Form 4 |
| PureTech Health plc | 10 percent owner | Apr 30, 2026 | OTHER | 0 | — | — | Form 4 |
| PureTech Health plc | 10 percent owner | Apr 30, 2026 | OTHER | 12,736,014 | — | — | Form 4 |
| PureTech Health plc | 10 percent owner | Apr 30, 2026 | OTHER | 2,681,265 | — | — | Form 4 |
| PureTech Health plc | 10 percent owner | Apr 30, 2026 | OTHER | 965,255 | — | — | Form 4 |